{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04835584",
            "orgStudyIdInfo": {
                "id": "KRT-232-117"
            },
            "organization": {
                "fullName": "Kartos Therapeutics, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "KRT-232 and TKI Study in Chronic Myeloid Leukemia",
            "officialTitle": "An Open-Label, Multicenter, Phase 1b/2 Study of the Safety and Efficacy of KRT-232 Combined With a Tyrosine Kinase Inhibitor (TKI) in Patients With Relapsed or Refractory Ph+ Chronic Myeloid Leukemia (CML)",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "krt-and-tki-study-in-chronic-myeloid-leukemia"
        },
        "statusModule": {
            "statusVerifiedDate": "2022-03",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2021-05-07",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-12-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-06-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-04-05",
            "studyFirstSubmitQcDate": "2021-04-05",
            "studyFirstPostDateStruct": {
                "date": "2021-04-08",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2022-03-04",
            "lastUpdatePostDateStruct": {
                "date": "2022-03-21",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Kartos Therapeutics, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This study evaluates KRT-232, a novel oral small molecule inhibitor of MDM2, for the treatment of patients with Ph+ Chronic Myeloid Leukemia (CML) who have relapsed or are refractory or intolerant to a Tyrosine Kinase Inhibitor (TKI).\n\nThis study is a global, open label Phase 1b/2 to determine the efficacy and safety of KRT-232 in patients with chronic phase CML (CML-CP) and accelerated phase (CML-AP) who have failed TKI treatments."
        },
        "conditionsModule": {
            "conditions": [
                "Chronic Myeloid Leukemia"
            ],
            "keywords": [
                "navtemadlin"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1",
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 109,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Part 1, KRT-232 combined with TKI (Dasatinib or Nilotinib) in patients with CML-CP",
                    "type": "EXPERIMENTAL",
                    "description": "KRT-232 will be administered orally, once daily (QD) on Days 1-7 in a 28-day cycle. TKI (dasatinib or nilotinib) will be administered orally, per locally prescribed dose and schedule.",
                    "interventionNames": [
                        "Drug: KRT-232",
                        "Drug: Dasatinib",
                        "Drug: Nilotinib"
                    ]
                },
                {
                    "label": "Part 2, Arm A (KRT-232 combined with Dasatinib in patients with CML-CP)",
                    "type": "EXPERIMENTAL",
                    "description": "KRT-232 will be administered orally, once daily (QD) on Days 1-7 in a 28-day cycle. Dasastinib will be administered orally, per locally prescribed dose and schedule.",
                    "interventionNames": [
                        "Drug: KRT-232",
                        "Drug: Dasatinib"
                    ]
                },
                {
                    "label": "Part 2, Arm B (KRT-232 combined with Nilotinib in patients with CML-CP)",
                    "type": "EXPERIMENTAL",
                    "description": "KRT-232 will be administered orally, once daily (QD) on Days 1-7 in a 28-day cycle. Nilotinib will be administered orally, per locally prescribed dose and schedule.",
                    "interventionNames": [
                        "Drug: KRT-232",
                        "Drug: Nilotinib"
                    ]
                },
                {
                    "label": "Part 2, Arm C (KRT-232 combined with Dasatinib or Nilotinib in patients with CML-AP)",
                    "type": "EXPERIMENTAL",
                    "description": "KRT-232 will be administered orally, once daily (QD) on Days 1-7 in a 28-day cycle. Dasatinib or Nilotinib will be administered orally, per locally prescribed dose and schedule.",
                    "interventionNames": [
                        "Drug: KRT-232",
                        "Drug: Dasatinib",
                        "Drug: Nilotinib"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "KRT-232",
                    "description": "KRT-232 is an experimental MDM2 inhibitor anticancer drug taken by mouth.",
                    "armGroupLabels": [
                        "Part 1, KRT-232 combined with TKI (Dasatinib or Nilotinib) in patients with CML-CP",
                        "Part 2, Arm A (KRT-232 combined with Dasatinib in patients with CML-CP)",
                        "Part 2, Arm B (KRT-232 combined with Nilotinib in patients with CML-CP)",
                        "Part 2, Arm C (KRT-232 combined with Dasatinib or Nilotinib in patients with CML-AP)"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Dasatinib",
                    "description": "Dasatinib is a Tyrosine Kinase Inhibitor anticancer drug taken by mouth.",
                    "armGroupLabels": [
                        "Part 1, KRT-232 combined with TKI (Dasatinib or Nilotinib) in patients with CML-CP",
                        "Part 2, Arm A (KRT-232 combined with Dasatinib in patients with CML-CP)",
                        "Part 2, Arm C (KRT-232 combined with Dasatinib or Nilotinib in patients with CML-AP)"
                    ],
                    "otherNames": [
                        "Dasatinib Zentiva"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Nilotinib",
                    "description": "Nilotinib is an Tyrosine Kinase Inhibitor anticancer drug taken by mouth.",
                    "armGroupLabels": [
                        "Part 1, KRT-232 combined with TKI (Dasatinib or Nilotinib) in patients with CML-CP",
                        "Part 2, Arm B (KRT-232 combined with Nilotinib in patients with CML-CP)",
                        "Part 2, Arm C (KRT-232 combined with Dasatinib or Nilotinib in patients with CML-AP)"
                    ],
                    "otherNames": [
                        "Tasigna"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Part 1: Maximum tolerated dose (MTD)/maximum administered dose (MAD) of KRT-232",
                    "description": "DLTs will be used to establish the MTD/MAD of KRT-232 in combination with dasatinib or nilotinib",
                    "timeFrame": "28 Days"
                },
                {
                    "measure": "Part 2, Arm A and B: Major molecular response (MMR) rate",
                    "description": "The proportion of subjects who achieved complete cytogenetic response (CCyR) or partial cytogenetic response (PCyR) according to modified ELN criteria",
                    "timeFrame": "6 months"
                },
                {
                    "measure": "Part 2, Arm C: Major hematological response (MaHR) rate",
                    "description": "The proportion of subjects who achieved MaHR according to modified ELN criteria",
                    "timeFrame": "6 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "CCyR rate",
                    "description": "The proportion of subjects who achieved CCyR or PCyR according to modified ELN criteria in Arms A and B",
                    "timeFrame": "12 months"
                },
                {
                    "measure": "MCyR rate",
                    "description": "The proportion of subjects who achieved CCyR or PCyR according to modified ELN criteria in Arm C",
                    "timeFrame": "47 months"
                },
                {
                    "measure": "Duration of response",
                    "description": "DOR (Kaplan-Meier estimate) defined as the time from first observation of response to progression/relapse or death, whichever comes first",
                    "timeFrame": "47 months"
                },
                {
                    "measure": "Rate of complete hematologic response (CHR)",
                    "description": "The proportion of subjects who achieve a CHR according to modified ELN criteria in Arms A and B",
                    "timeFrame": "47 months"
                },
                {
                    "measure": "Progression-free survival (PFS) in each Arm",
                    "description": "PFS is defined as the time from the first treatment dose date to progression/relapse or death, whichever comes first",
                    "timeFrame": "47 months"
                },
                {
                    "measure": "Overall survival (OS) in each Arm",
                    "description": "OS is defined as the time from the first treatment dose date to death from any cause",
                    "timeFrame": "47 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Phase 1b and Phase 2 Arms A and B: Documented TP53wt, Ph+, BCR-ABL+ CML-CP\n* Phase 2 Arm C ONLY: Documented TP53wt, Ph+, BCR-ABL+ CML-AP\n* Subject is resistant (relapsed or refractory) and/or intolerant to at least 1 prior TKI.\n* Adults \u2265 18 years of age.\n* ECOG performance status of 0 to 2\n* Adequate hematologic, hepatic, and renal functions\n\nExclusion Criteria:\n\n* Phase 1b and Phase 2 Arms A and B: Documented Ph+, BCR-ABL+ CML-AP\n* Documented Ph+, BCR-ABL+ CML-BC\n* Known T315I mutation.\n* Prior treatment with MDM2 antagonist therapies.\n* Intolerance to current TKI therapy.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "John Mei",
                    "role": "CONTACT",
                    "phone": "650-542-0136",
                    "email": "jmei@kartosthera.com"
                }
            ],
            "locations": [
                {
                    "facility": "University of Alabama Birmingham",
                    "status": "RECRUITING",
                    "city": "Birmingham",
                    "state": "Alabama",
                    "zip": "35294",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.52066,
                        "lon": -86.80249
                    }
                },
                {
                    "facility": "Georgia Cancer Center at Augusta University",
                    "status": "RECRUITING",
                    "city": "Augusta",
                    "state": "Georgia",
                    "zip": "30912",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.47097,
                        "lon": -81.97484
                    }
                },
                {
                    "facility": "University of Pittsburgh Medical Center",
                    "status": "RECRUITING",
                    "city": "Pittsburgh",
                    "state": "Pennsylvania",
                    "zip": "15232",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.44062,
                        "lon": -79.99589
                    }
                },
                {
                    "facility": "Texas Oncology- Sammons CC at Baylor",
                    "status": "RECRUITING",
                    "city": "Dallas",
                    "state": "Texas",
                    "zip": "75246",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 32.78306,
                        "lon": -96.80667
                    }
                },
                {
                    "facility": "Medical College of Wisconsin",
                    "status": "RECRUITING",
                    "city": "Milwaukee",
                    "state": "Wisconsin",
                    "zip": "53226",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 43.0389,
                        "lon": -87.90647
                    }
                },
                {
                    "facility": "Princess Margaret Cancer Center",
                    "status": "RECRUITING",
                    "city": "Toronto",
                    "state": "Ontario",
                    "zip": "M5G 2C1",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 43.70011,
                        "lon": -79.4163
                    }
                },
                {
                    "facility": "Centre Leon Berard",
                    "status": "RECRUITING",
                    "city": "Lyon",
                    "zip": "69008",
                    "country": "France",
                    "geoPoint": {
                        "lat": 45.74848,
                        "lon": 4.84669
                    }
                },
                {
                    "facility": "APHM Hopital de la Timone",
                    "status": "RECRUITING",
                    "city": "Marseille",
                    "zip": "13005",
                    "country": "France",
                    "geoPoint": {
                        "lat": 43.29551,
                        "lon": 5.38958
                    }
                },
                {
                    "facility": "Institut Paoli-Calmettes",
                    "status": "RECRUITING",
                    "city": "Marseille",
                    "zip": "13009",
                    "country": "France",
                    "geoPoint": {
                        "lat": 43.29551,
                        "lon": 5.38958
                    }
                },
                {
                    "facility": "Centre Hospitalier Lyon Sud",
                    "status": "RECRUITING",
                    "city": "Saint-Genis-Laval",
                    "zip": "69310",
                    "country": "France",
                    "geoPoint": {
                        "lat": 45.69558,
                        "lon": 4.7934
                    }
                },
                {
                    "facility": "Policlinico di Milano Ospedale Maggiore | Fondazione IRCCS Ca' Granda",
                    "status": "RECRUITING",
                    "city": "Milano",
                    "state": "MI",
                    "zip": "20122",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 45.46427,
                        "lon": 9.18951
                    }
                },
                {
                    "facility": "Azienda Ospedaliero - Universitaria Mater Domini",
                    "status": "RECRUITING",
                    "city": "Catanzaro",
                    "zip": "88100",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 38.88247,
                        "lon": 16.60086
                    }
                },
                {
                    "facility": "Istituto Romagnolo per lo Studio dei Tumori Dino Amadori",
                    "status": "RECRUITING",
                    "city": "Meldola FC",
                    "zip": "47014",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 44.12775,
                        "lon": 12.0626
                    }
                },
                {
                    "facility": "Fondazione IRCCS Policlinico San Matteo",
                    "status": "RECRUITING",
                    "city": "Pavia",
                    "zip": "27100",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 45.19205,
                        "lon": 9.15917
                    }
                },
                {
                    "facility": "Kyungpook National University Hospital",
                    "status": "RECRUITING",
                    "city": "Daegu",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 35.87028,
                        "lon": 128.59111
                    }
                },
                {
                    "facility": "Samsung Medical Center",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "zip": "135-710",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Seoul National University Hospital",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Severance Hospital",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Pratia Onkologia Katowice",
                    "status": "RECRUITING",
                    "city": "Katowice",
                    "zip": "40-519",
                    "country": "Poland",
                    "geoPoint": {
                        "lat": 50.25841,
                        "lon": 19.02754
                    }
                },
                {
                    "facility": "National Medical Research Center of Hematology",
                    "status": "RECRUITING",
                    "city": "Moscow",
                    "zip": "125167",
                    "country": "Russian Federation",
                    "geoPoint": {
                        "lat": 55.75222,
                        "lon": 37.61556
                    }
                },
                {
                    "facility": "Almazov National Medical Research Center",
                    "status": "RECRUITING",
                    "city": "Saint Petersburg",
                    "zip": "197341",
                    "country": "Russian Federation",
                    "geoPoint": {
                        "lat": 59.93863,
                        "lon": 30.31413
                    }
                },
                {
                    "facility": "Samara State Medical University",
                    "status": "RECRUITING",
                    "city": "Samara",
                    "zip": "443001",
                    "country": "Russian Federation",
                    "geoPoint": {
                        "lat": 53.20007,
                        "lon": 50.15
                    }
                },
                {
                    "facility": "Cl\u00ednica Universidad de Navarra",
                    "status": "RECRUITING",
                    "city": "Madrid",
                    "state": "Navarra",
                    "zip": "28027",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "Clinica Universidad de Navarra",
                    "status": "RECRUITING",
                    "city": "Pamplona",
                    "state": "Navarra",
                    "zip": "31008",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 42.81687,
                        "lon": -1.64323
                    }
                },
                {
                    "facility": "Hospital Universitari Vall d'Hebron",
                    "status": "RECRUITING",
                    "city": "Barcelona",
                    "zip": "08035",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 41.38879,
                        "lon": 2.15899
                    }
                },
                {
                    "facility": "Hospital Universitario La Paz",
                    "status": "RECRUITING",
                    "city": "Madrid",
                    "zip": "28046",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000007938",
                    "term": "Leukemia"
                },
                {
                    "id": "D000007951",
                    "term": "Leukemia, Myeloid"
                },
                {
                    "id": "D000015464",
                    "term": "Leukemia, Myelogenous, Chronic, BCR-ABL Positive"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000006402",
                    "term": "Hematologic Diseases"
                },
                {
                    "id": "D000009196",
                    "term": "Myeloproliferative Disorders"
                },
                {
                    "id": "D000001855",
                    "term": "Bone Marrow Diseases"
                },
                {
                    "id": "D000002908",
                    "term": "Chronic Disease"
                },
                {
                    "id": "D000020969",
                    "term": "Disease Attributes"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M10945",
                    "name": "Leukemia",
                    "asFound": "Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M18123",
                    "name": "Leukemia, Myelogenous, Chronic, BCR-ABL Positive",
                    "asFound": "Chronic Myeloid Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10955",
                    "name": "Leukemia, Myeloid",
                    "asFound": "Myeloid Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M9490",
                    "name": "Hematologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M12149",
                    "name": "Myeloproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M5134",
                    "name": "Bone Marrow Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M6147",
                    "name": "Chronic Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "M22700",
                    "name": "Disease Attributes",
                    "relevance": "LOW"
                },
                {
                    "id": "T1303",
                    "name": "Chronic Graft Versus Host Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "T1309",
                    "name": "Chronic Myeloid Leukemia",
                    "asFound": "Chronic Myeloid Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "T3995",
                    "name": "Myeloid Leukemia",
                    "asFound": "Myeloid Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "T1311",
                    "name": "Chronic Myeloproliferative Disorders",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC15",
                    "name": "Blood and Lymph Conditions"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000069439",
                    "term": "Dasatinib"
                },
                {
                    "id": "C000498826",
                    "term": "Nilotinib"
                }
            ],
            "ancestors": [
                {
                    "id": "D000092004",
                    "term": "Tyrosine Kinase Inhibitors"
                },
                {
                    "id": "D000047428",
                    "term": "Protein Kinase Inhibitors"
                },
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M145649",
                    "name": "Nilotinib",
                    "asFound": "Rating",
                    "relevance": "HIGH"
                },
                {
                    "id": "M410",
                    "name": "Dasatinib",
                    "asFound": "Specified",
                    "relevance": "HIGH"
                },
                {
                    "id": "M2889",
                    "name": "Tyrosine Kinase Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M25820",
                    "name": "Protein Kinase Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "T22",
                    "name": "Tyrosine",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "AA",
                    "name": "Amino Acids"
                }
            ]
        }
    },
    "hasResults": false
}